BACKGROUND: Analytic models of Alzheimer's disease (AD) tend to focus on one type of symptom and assume implicitly that no measurement error is present. These tendencies render changes in symptom domains difficult to model mathematically, although latent variable methods can accommodate both multiple symptom domains and error. This study formulated and compared underlying (latent) factor structures representing previously reported dependence and independence of symptoms of cognitive decline, functional impairment, and behavioral disturbance in AD. METHODS: In confirmatory factor analyses of data from 2 cohorts of AD patients, 2 levels of latent variables were conceptualized. One general neurologic factor represented disease, and symptom factors represented cognition, function, and behavior. Two "null" models had either a single factor or 3 symptom factors. Two 2-level models treated the general factor as underlying both the observed variables and the symptom factors or treated the symptom factors as explaining variability in the observed variables after taking the general factor into account ("residualized"). RESULTS/ CONCLUSIONS: The residualized model fit the data in both cohorts significantly better than the other models, and relations in this model between some observed and latent variables were different across cohorts. Neither cohort supported a single factor model; both cohorts independently supported a residualized model that may permit differentiation of symptom- from disease-modifying effects of treatment.
BACKGROUND: Analytic models of Alzheimer's disease (AD) tend to focus on one type of symptom and assume implicitly that no measurement error is present. These tendencies render changes in symptom domains difficult to model mathematically, although latent variable methods can accommodate both multiple symptom domains and error. This study formulated and compared underlying (latent) factor structures representing previously reported dependence and independence of symptoms of cognitive decline, functional impairment, and behavioral disturbance in AD. METHODS: In confirmatory factor analyses of data from 2 cohorts of ADpatients, 2 levels of latent variables were conceptualized. One general neurologic factor represented disease, and symptom factors represented cognition, function, and behavior. Two "null" models had either a single factor or 3 symptom factors. Two 2-level models treated the general factor as underlying both the observed variables and the symptom factors or treated the symptom factors as explaining variability in the observed variables after taking the general factor into account ("residualized"). RESULTS/ CONCLUSIONS: The residualized model fit the data in both cohorts significantly better than the other models, and relations in this model between some observed and latent variables were different across cohorts. Neither cohort supported a single factor model; both cohorts independently supported a residualized model that may permit differentiation of symptom- from disease-modifying effects of treatment.
Authors: P S Aisen; K L Davis; J D Berg; K Schafer; K Campbell; R G Thomas; M F Weiner; M R Farlow; M Sano; M Grundman; L J Thal Journal: Neurology Date: 2000-02-08 Impact factor: 9.910
Authors: Rochelle E Tractenberg; Myron F Weiner; Marian B Patterson; Anthony Gamst; Leon J Thal Journal: J Geriatr Psychiatry Neurol Date: 2002 Impact factor: 2.680
Authors: Stephanie Cosentino; Laura B Zahodne; Jason Brandt; Deborah Blacker; Marilyn Albert; Bruno Dubois; Yaakov Stern Journal: Alzheimers Dement Date: 2014-03-18 Impact factor: 21.566
Authors: Lisa L Barnes; Futoshi Yumoto; Ana Capuano; Robert S Wilson; David A Bennett; Rochelle E Tractenberg Journal: J Int Neuropsychol Soc Date: 2015-11-13 Impact factor: 2.892
Authors: Nina Wubben; Miriam Haaksma; Inez H G B Ramakers; Wiesje M van der Flier; Frans R J Verhey; Marcel G M Olde Rikkert; René J F Melis Journal: Int J Geriatr Psychiatry Date: 2022-05 Impact factor: 3.850
Authors: Miriam L Haaksma; Amaia Calderón-Larrañaga; Marcel G M Olde Rikkert; René J F Melis; Jeannie-Marie S Leoutsakos Journal: Int J Geriatr Psychiatry Date: 2018-05-15 Impact factor: 3.485